Straumann Holding AG Income from Discontinued Operations 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly income from discontinued operations history and growth rate from 2012 to 2024. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
  • Straumann Holding AG income from discontinued operations for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG income from discontinued operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual income from discontinued operations for 2024 was $-0.079B, a 0% decline from 2023.
  • Straumann Holding AG annual income from discontinued operations for 2023 was $0B, a 0% decline from 2022.
  • Straumann Holding AG annual income from discontinued operations for 2022 was $0B, a 0% decline from 2021.
Straumann Holding AG Annual Income from Discontinued Operations
(Millions of US $)
2024 $-79
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
Straumann Holding AG Quarterly Income from Discontinued Operations
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $21.909B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.604B 21.88
Becton Dickinson (BDX) United States $50.274B 12.45
Cardinal Health (CAH) United States $36.816B 19.28
Labcorp (LH) United States $20.885B 16.94
Cooper (COO) United States $16.582B 21.99
West Pharmaceutical Services (WST) United States $15.565B 32.63
Align Technology (ALGN) United States $13.648B 27.09
Henry Schein (HSIC) United States $8.770B 15.04
Merit Medical Systems (MMSI) United States $5.841B 28.24
DENTSPLY SIRONA (XRAY) United States $3.328B 9.94
CONMED (CNMD) United States $1.865B 13.96
STAAR Surgical (STAA) United States $0.952B 0.00
Lifevantage (LFVN) United States $0.169B 17.39
Pro-Dex (PDEX) United States $0.141B 15.40